Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Unknown × NETWORK × Adenocarcinoma × Clear all

Phase

Status

Completed 2 Unknown 1 Terminated 1 Recruiting 1 Active not recruiting 1

Sponsor Class

OTHER 43 INDUSTRY 7 OTHER_GOV 3 UNKNOWN 1 NETWORK 1

Study Type

Interventional 1

Sponsor

Cancer Type

Tumor-Agnostic 1

Conditions

Leukemia, Myeloid, Acute 11 Breast Neoplasms 11 Colorectal Neoplasms 9 Rectal Neoplasms 7 Fallopian Tube Neoplasms 7 Neoplasms 6 Carcinoma, Non-Small-Cell Lung 6 Leukemia 5 Head and Neck Neoplasms 5 Uterine Cervical Neoplasms 4 Squamous Cell Carcinoma of Head and Neck 4 Prostatic Neoplasms 4 Ovarian Neoplasms 4 Multiple Myeloma 4 Vulvar Neoplasms 3 Stomach Neoplasms 3 Recurrence 3 Precursor Cell Lymphoblastic Leukemia-Lymphoma 3 Pancreatic Neoplasms 3 Lymphoma 3 Leukemia, Lymphocytic, Chronic, B-Cell 3 Fatigue 3 Depression 3 Carcinoma, Hepatocellular 3 Urinary Bladder Neoplasms 2 Stress Disorders, Post-Traumatic 2 Rhabdomyosarcoma 2 Neurotoxicity Syndromes 2 Myelodysplastic Syndromes 2 Melanoma 2

Interventions

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02773524 2022-01-13

INTEGRATEIIa

Australasian Gastro-Intestinal Trials Group

Phase 3 Unknown

Adenocarcinoma, Carcinoma, Neoplasm Metastasis

Data powered by HemOnc (CC BY 4.0) Colophon ⚡